Quality assurance: protocol for assessing the rifampicin bioavailability of combined formulations in healthy volunteers.
D000293:Adolescent; D000328:Adult; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D000995:Antitubercular Agents / Q000008:administration & dosage*; D001682:Biological Availability; D002985:Clinical Protocols; D004338:Drug Combinations; D006801:Humans; D008875:Middle Aged; D018579:Patient Selection; D011786:Quality Control; D016032:Randomized Controlled Trials as Topic; D012293:Rifampin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D004338:Drug Combinations; D012293:Rifampin